nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—Triamcinolone—psoriatic arthritis	0.371	0.424	CbGbCtD
Tetrahydrobiopterin—PTGS2—Betamethasone—psoriatic arthritis	0.318	0.364	CbGbCtD
Tetrahydrobiopterin—PTGS2—Dexamethasone—psoriatic arthritis	0.185	0.212	CbGbCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Auranofin—psoriatic arthritis	0.00368	0.0387	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Auranofin—psoriatic arthritis	0.00297	0.0313	CcSEcCtD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—IL23A—psoriatic arthritis	0.00245	0.154	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.00244	0.159	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.00241	0.156	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.00241	0.156	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.00235	0.153	CbGdCrCtD
Tetrahydrobiopterin—NOS3—Effects of Nitric Oxide—NOS2—psoriatic arthritis	0.00205	0.129	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—ACE—psoriatic arthritis	0.00193	0.122	CbGpPWpGaD
Tetrahydrobiopterin—Oropharyngeal pain—Triamcinolone—psoriatic arthritis	0.00163	0.0172	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Auranofin—psoriatic arthritis	0.00159	0.0167	CcSEcCtD
Tetrahydrobiopterin—Contusion—Dexamethasone—psoriatic arthritis	0.00154	0.0162	CcSEcCtD
Tetrahydrobiopterin—Contusion—Betamethasone—psoriatic arthritis	0.00154	0.0162	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00148	0.0155	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.00147	0.0957	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.00145	0.0942	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.00145	0.0942	CbGdCrCtD
Tetrahydrobiopterin—Abdominal pain—Auranofin—psoriatic arthritis	0.00143	0.015	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.00142	0.0921	CbGdCrCtD
Tetrahydrobiopterin—Contusion—Prednisone—psoriatic arthritis	0.00135	0.0141	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Auranofin—psoriatic arthritis	0.00124	0.013	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Auranofin—psoriatic arthritis	0.00115	0.0121	CcSEcCtD
Tetrahydrobiopterin—Rash—Auranofin—psoriatic arthritis	0.00114	0.012	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Auranofin—psoriatic arthritis	0.00114	0.012	CcSEcCtD
Tetrahydrobiopterin—Nausea—Auranofin—psoriatic arthritis	0.00107	0.0113	CcSEcCtD
Tetrahydrobiopterin—Irritability—Methylprednisolone—psoriatic arthritis	0.00103	0.0108	CcSEcCtD
Tetrahydrobiopterin—Hyperkinesia—Prednisone—psoriatic arthritis	0.00102	0.0108	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Methotrexate—psoriatic arthritis	0.000999	0.0105	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.000996	0.0627	CbGpPWpGaD
Tetrahydrobiopterin—Irritability—Betamethasone—psoriatic arthritis	0.000934	0.00982	CcSEcCtD
Tetrahydrobiopterin—Irritability—Dexamethasone—psoriatic arthritis	0.000934	0.00982	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.000891	0.00937	CcSEcCtD
Tetrahydrobiopterin—Urine output increased—Methotrexate—psoriatic arthritis	0.000887	0.00933	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Prednisolone—psoriatic arthritis	0.000886	0.00931	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.000866	0.00911	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.000852	0.00896	CcSEcCtD
Tetrahydrobiopterin—NOS3—Nitric oxide stimulates guanylate cyclase—NOS2—psoriatic arthritis	0.00085	0.0536	CbGpPWpGaD
Tetrahydrobiopterin—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000829	0.00872	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methylprednisolone—psoriatic arthritis	0.000829	0.00872	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.000819	0.00861	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000817	0.00859	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.000814	0.00856	CcSEcCtD
Tetrahydrobiopterin—Irritability—Prednisone—psoriatic arthritis	0.000813	0.00855	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.000813	0.00855	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Methotrexate—psoriatic arthritis	0.000811	0.00853	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—REL—psoriatic arthritis	0.000779	0.0491	CbGpPWpGaD
Tetrahydrobiopterin—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000743	0.00781	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000743	0.00781	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00074	0.00778	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Betamethasone—psoriatic arthritis	0.000739	0.00777	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.000739	0.00777	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.000728	0.0459	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Prednisone—psoriatic arthritis	0.000689	0.00724	CcSEcCtD
Tetrahydrobiopterin—Irritability—Methotrexate—psoriatic arthritis	0.00068	0.00715	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000671	0.00705	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000648	0.00681	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000647	0.00681	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Prednisone—psoriatic arthritis	0.000644	0.00677	CcSEcCtD
Tetrahydrobiopterin—NOS3—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—psoriatic arthritis	0.000643	0.0405	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Prednisolone—psoriatic arthritis	0.000612	0.00643	CcSEcCtD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—NOS2—psoriatic arthritis	0.000597	0.0376	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000576	0.00606	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Methotrexate—psoriatic arthritis	0.000575	0.00605	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000572	0.00601	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.000572	0.036	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Triamcinolone—psoriatic arthritis	0.000567	0.00596	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Triamcinolone—psoriatic arthritis	0.000563	0.00592	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Methylprednisolone—psoriatic arthritis	0.000561	0.0059	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000552	0.0058	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Methotrexate—psoriatic arthritis	0.000549	0.00577	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methotrexate—psoriatic arthritis	0.000549	0.00577	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000548	0.00576	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00053	0.00557	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000529	0.00556	CcSEcCtD
Tetrahydrobiopterin—Infection—Triamcinolone—psoriatic arthritis	0.000526	0.00554	CcSEcCtD
Tetrahydrobiopterin—Infection—Methylprednisolone—psoriatic arthritis	0.000525	0.00552	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000518	0.00545	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000514	0.0054	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Prednisone—psoriatic arthritis	0.000513	0.0054	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Dexamethasone—psoriatic arthritis	0.00051	0.00537	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Betamethasone—psoriatic arthritis	0.00051	0.00537	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—psoriatic arthritis	0.000489	0.00514	CcSEcCtD
Tetrahydrobiopterin—TH—Monoamine Transport—TNF—psoriatic arthritis	0.000484	0.0305	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000483	0.00508	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000482	0.00507	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000481	0.00506	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000481	0.00506	CcSEcCtD
Tetrahydrobiopterin—Infection—Betamethasone—psoriatic arthritis	0.000478	0.00502	CcSEcCtD
Tetrahydrobiopterin—Infection—Dexamethasone—psoriatic arthritis	0.000478	0.00502	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000472	0.00496	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000472	0.00496	CcSEcCtD
Tetrahydrobiopterin—Agitation—Prednisone—psoriatic arthritis	0.000471	0.00496	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000466	0.00491	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000465	0.00489	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—CRP—psoriatic arthritis	0.000459	0.029	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Prednisone—psoriatic arthritis	0.000445	0.00467	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000444	0.00467	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000438	0.00461	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000438	0.00461	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Prednisone—psoriatic arthritis	0.000437	0.00459	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000434	0.00456	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000432	0.00455	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Methotrexate—psoriatic arthritis	0.000429	0.00451	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000425	0.00446	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000423	0.00445	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Betamethasone—psoriatic arthritis	0.000423	0.00445	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000419	0.00441	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000419	0.0044	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000418	0.0044	CcSEcCtD
Tetrahydrobiopterin—Infection—Prednisone—psoriatic arthritis	0.000416	0.00437	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000415	0.00437	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000415	0.00437	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Prednisone—psoriatic arthritis	0.000411	0.00432	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Prednisone—psoriatic arthritis	0.000407	0.00428	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000393	0.00413	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000393	0.00413	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00039	0.00411	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—NOS2—psoriatic arthritis	0.00039	0.0246	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00039	0.0041	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000381	0.00401	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Prednisolone—psoriatic arthritis	0.000381	0.00401	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Betamethasone—psoriatic arthritis	0.00038	0.004	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00038	0.004	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00038	0.004	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00038	0.004	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000378	0.0238	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Methotrexate—psoriatic arthritis	0.000374	0.00393	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Methotrexate—psoriatic arthritis	0.000371	0.00391	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Prednisone—psoriatic arthritis	0.000369	0.00388	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—psoriatic arthritis	0.000365	0.00384	CcSEcCtD
Tetrahydrobiopterin—Rash—Prednisolone—psoriatic arthritis	0.000363	0.00382	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Prednisolone—psoriatic arthritis	0.000363	0.00382	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000363	0.00381	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000362	0.0038	CcSEcCtD
Tetrahydrobiopterin—Headache—Prednisolone—psoriatic arthritis	0.000361	0.0038	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Triamcinolone—psoriatic arthritis	0.00035	0.00368	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00035	0.00368	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Methylprednisolone—psoriatic arthritis	0.00035	0.00368	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—psoriatic arthritis	0.000348	0.00366	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000343	0.00361	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000342	0.0036	CcSEcCtD
Tetrahydrobiopterin—Nausea—Prednisolone—psoriatic arthritis	0.000342	0.0036	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methotrexate—psoriatic arthritis	0.00034	0.00357	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Triamcinolone—psoriatic arthritis	0.000337	0.00354	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000336	0.00354	CcSEcCtD
Tetrahydrobiopterin—Rash—Triamcinolone—psoriatic arthritis	0.000334	0.00351	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Triamcinolone—psoriatic arthritis	0.000334	0.00351	CcSEcCtD
Tetrahydrobiopterin—Rash—Methylprednisolone—psoriatic arthritis	0.000333	0.00351	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000333	0.0035	CcSEcCtD
Tetrahydrobiopterin—Headache—Triamcinolone—psoriatic arthritis	0.000332	0.00349	CcSEcCtD
Tetrahydrobiopterin—Headache—Methylprednisolone—psoriatic arthritis	0.000331	0.00348	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Prednisone—psoriatic arthritis	0.000331	0.00348	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Prednisone—psoriatic arthritis	0.000331	0.00348	CcSEcCtD
Tetrahydrobiopterin—NOS3—Platelet homeostasis—NOS2—psoriatic arthritis	0.000331	0.0209	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000329	0.00346	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000329	0.00346	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000319	0.00335	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Dexamethasone—psoriatic arthritis	0.000318	0.00334	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Betamethasone—psoriatic arthritis	0.000318	0.00334	CcSEcCtD
Tetrahydrobiopterin—Nausea—Triamcinolone—psoriatic arthritis	0.000315	0.00331	CcSEcCtD
Tetrahydrobiopterin—Nausea—Methylprednisolone—psoriatic arthritis	0.000314	0.0033	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000308	0.00324	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—psoriatic arthritis	0.000308	0.00324	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Dexamethasone—psoriatic arthritis	0.000306	0.00321	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Betamethasone—psoriatic arthritis	0.000306	0.00321	CcSEcCtD
Tetrahydrobiopterin—Rash—Dexamethasone—psoriatic arthritis	0.000303	0.00319	CcSEcCtD
Tetrahydrobiopterin—Rash—Betamethasone—psoriatic arthritis	0.000303	0.00319	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000303	0.00319	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Betamethasone—psoriatic arthritis	0.000303	0.00319	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000302	0.00318	CcSEcCtD
Tetrahydrobiopterin—Headache—Betamethasone—psoriatic arthritis	0.000301	0.00317	CcSEcCtD
Tetrahydrobiopterin—Headache—Dexamethasone—psoriatic arthritis	0.000301	0.00317	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Prednisone—psoriatic arthritis	0.000286	0.00301	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000286	0.00301	CcSEcCtD
Tetrahydrobiopterin—Nausea—Betamethasone—psoriatic arthritis	0.000286	0.003	CcSEcCtD
Tetrahydrobiopterin—Nausea—Dexamethasone—psoriatic arthritis	0.000286	0.003	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Prednisone—psoriatic arthritis	0.000277	0.00291	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—psoriatic arthritis	0.000277	0.00291	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000277	0.00291	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Prednisone—psoriatic arthritis	0.000266	0.0028	CcSEcCtD
Tetrahydrobiopterin—Rash—Prednisone—psoriatic arthritis	0.000264	0.00278	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Prednisone—psoriatic arthritis	0.000264	0.00277	CcSEcCtD
Tetrahydrobiopterin—Headache—Prednisone—psoriatic arthritis	0.000262	0.00276	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000258	0.00271	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriatic arthritis	0.000257	0.0162	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Prednisone—psoriatic arthritis	0.000249	0.00262	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000239	0.00252	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	0.000237	0.0149	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriatic arthritis	0.000235	0.0148	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Methotrexate—psoriatic arthritis	0.000231	0.00243	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—NOS2—psoriatic arthritis	0.000224	0.0141	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Methotrexate—psoriatic arthritis	0.000222	0.00234	CcSEcCtD
Tetrahydrobiopterin—Rash—Methotrexate—psoriatic arthritis	0.000221	0.00232	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—psoriatic arthritis	0.00022	0.00232	CcSEcCtD
Tetrahydrobiopterin—Headache—Methotrexate—psoriatic arthritis	0.000219	0.00231	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—TNF—psoriatic arthritis	0.000208	0.0131	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Methotrexate—psoriatic arthritis	0.000208	0.00219	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	0.000173	0.0109	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	0.000136	0.00858	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.000135	0.00849	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000103	0.00646	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—NOS2—psoriatic arthritis	9.72e-05	0.00613	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriatic arthritis	9.59e-05	0.00604	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—NOS2—psoriatic arthritis	7.42e-05	0.00467	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NOS2—psoriatic arthritis	6.59e-05	0.00416	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—TNF—psoriatic arthritis	6.1e-05	0.00385	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TNF—psoriatic arthritis	4.83e-05	0.00304	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NOS2—psoriatic arthritis	3.59e-05	0.00226	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	3.28e-05	0.00207	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS2—psoriatic arthritis	1.47e-05	0.000925	CbGpPWpGaD
